A new Patient‐Reported Outcome Scale to assess autoimmune Encephalitis: PROSE
Annals of Neurology · 2026
DOI: 10.1002/ana.78287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Juliette Brenner und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Encephalitis, Hashimoto Disease. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Autoimmune encephalitis (AIE) has long‐lasting effects. Generic clinical assessment‐scales insufficiently capture disease‐specific sequelae. Patient‐reported outcome measures (PROMs) assess outcomes important to patients, ensuring relevance in the clinic and trials. We developed a disease‐specific patient‐reported outcome scale for encephalitis (PROSE).
Methods
Existing PROM‐items (n = 235) were evaluated for content‐validity and supplemented with focus‐group‐derived items. Patients with a history of anti‐NMDAR, anti‐LGI1, or anti‐CASPR2 encephalitis completed the preliminary item pool (n = 166). To refine and reduce the item‐pool and create the PROSE, we conducted item‐, factor‐, and Rasch‐analyses. Test–retest reliability was assessed over 2 weeks and convergent‐validity against established measures.
Results
The analysis included data from 202 patients with anti‐LGI1 (n = 97), anti‐NMDAR (n = 85), and anti‐CASPR2 (n = 20) encephalitis, median 3.5 years from diagnosis (range = 0.05–14; n = 41
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
- Department of Neurology, Catharina Hospital, Eindhoven, The Netherlands.
- Department of Neurology, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
- Department of Neurology, Haaglanden Medical Centre, The Hague, The Netherlands.
- Department of Immunology, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands.
- Encephalitis International, Malton, UK.
ORCID-Profile: Juliette Brenner, Yvette S Crijnen, Robin W van Steenhoven
Zitieren
APA
Brenner, J., Crijnen, Y. S., Kulderij, I., Olijslagers, S. H. C., Ruhe, C. J., Tolido, A. A. G., Kersten, L. P., Verkoelen, J. C. P., Kret, C. N., Thomassen, B., van Wijnen, F. I., de Vries, J. M., Bienfait, T. M., Brand, T., Kerstens, J., van Steenhoven, R. W., Bastiaansen, A. E. M., de Bruijn, M. A. A. M., van Sonderen, A., …, & Titulaer, M. J. (2026). A new Patient‐Reported Outcome Scale to assess autoimmune Encephalitis: PROSE. Annals of Neurology. https://doi.org/10.1002/ana.78287
Vancouver
Brenner J, Crijnen YS, Kulderij I, Olijslagers SHC, Ruhe CJ, Tolido AAG, et al. A new Patient‐Reported Outcome Scale to assess autoimmune Encephalitis: PROSE. Annals of Neurology. 2026. doi:10.1002/ana.78287
BibTeX
@article{Brenner2026,
author = {Brenner, Juliette and Crijnen, Yvette S and Kulderij, Ilse and Olijslagers, Sammy H C and Ruhe, Cinthia J and Tolido, Anke A G and Kersten, Laura P and Verkoelen, Julia C P and Kret, Chelsey N and Thomassen, Brigit and van Wijnen, Finn I and de Vries, Juna M and Bienfait, Tessa M and Brand, Tessa and Kerstens, Jeroen and van Steenhoven, Robin W and Bastiaansen, Anna E M and de Bruijn, Marienke A A M and van Sonderen, Agnes and Veenbergen, Sharon and Easton, Ava and Sillevis Smitt, Peter A E and van den Berg, Esther and Mandarakas, Melissa and Titulaer, Maarten J},
title = {A new Patient‐Reported Outcome Scale to assess autoimmune Encephalitis: PROSE},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78287}
}
EUVIMED